CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 4 Open-market buy Chief Financial Officer bought 3,814 shares at an average $0.75 ($2,870)
- 4 Open-market buy Director bought 4,000 shares at $0.69 ($2,767)
- 4 Open-market buy Chief Executive Officer bought 3,580 shares at $0.60 ($2,158)
- 4 Open-market buy Director bought 100 shares at $4.60 ($460)
- 4 Open-market buy Chief Financial Officer bought 800 shares at an average $4.55 ($3,640)
- 4 Open-market buy Chief Executive Officer bought 1,400 shares at $4.70 ($6,580)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 17 of 18 · 345 filings